Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck KGaA
Merck KGaA
Merck KGaA shares slide after outlook cut on tariff, currency risks
MSN/Wall St Journal
Thu, 05/15/25 - 10:53 am
Merck KGaA
earnings
tariffs
Germany’s Merck drops China surcharge on orders after US-China tariff deal
Pharma Live
Wed, 05/14/25 - 09:53 am
Merck KGaA
China
tariffs
Germany’s Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks
Investing.com
Mon, 04/28/25 - 09:37 am
Merck KGaA
M&A
SpringWorks Therapeutics
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Yahoo/Reuters
Thu, 04/24/25 - 09:12 pm
Merck KGaA
SpringWorks Therapeutics
M&A
Merck Group pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win
Fierce Biotech
Tue, 04/1/25 - 11:36 am
Merck KGaA
pimicotinib
Abbisko Therapeutics
Merck KGaA fails midphase lupus trial, says totality of data support further development
Fierce Biotech
Thu, 03/6/25 - 11:06 am
Merck KGaA
clinical trials
lupus
enpatoran
Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Marketscreener
Mon, 02/10/25 - 10:16 am
Merck KGaA
M&A
SpringWorks Therapeutics
Merck KGaA says high asset prices call for prudent M&A approach
MSN/Reuters
Thu, 01/23/25 - 11:48 am
Merck KGaA
Belén Garijo
M&A
Merck KGaA's phase 3 rare tumor trial hits goal, teeing up rivalry with Daiichi and Ono
Fierce Biotech
Tue, 11/12/24 - 09:47 am
Merck KGaA
tenosynovial giant cell tumors
clinical trials
pimicotinib
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis
After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound
Fierce Pharma
Wed, 08/7/24 - 11:00 pm
Merck KGaA
earnings
CDMOs
Takeda to cut another 220 jobs in Massachusetts, while Merck KGaA plots its own layoffs
Fierce Pharma
Tue, 07/2/24 - 11:12 am
Takeda
Merck KGaA
layoffs
Massachusetts
Merck KGaA cans head and neck cancer drug once hailed as big hope
Pharmaphorum
Tue, 06/25/24 - 11:49 am
Merck KGaA
head and neck cancer
clinical trials
xevinapant
Merck KGaA's MilliporeSigma devotes €62M to new quality control building in Germany
Fierce Pharma
Fri, 06/14/24 - 11:22 am
Merck KGaA
MilliporeSigma
quality control
drug manufacturing
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
Fierce Biotech
Tue, 06/4/24 - 11:33 am
Merck KGaA
Biolojic Design
drug discovery
antibody-drug conjugates
oncology
ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space
Fierce Pharma
Thu, 05/23/24 - 09:52 pm
ASCO 2024
Merck KGaA
Bavencio
Pfizer
Inlyta
kidney cancer
clinical tirals
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive
Thu, 05/23/24 - 09:37 pm
Merck KGaA
M&A
MilliporeSigma
Gamma Biosciences
gene therapy
Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China
Fierce Pharma
Wed, 05/22/24 - 10:22 pm
Merck KGaA
MilliporeSigma
DOJ
China
Merck KGaA's CDMO unit continues to slide but company sees an uptick coming
Fierce Pharma
Wed, 05/15/24 - 10:50 pm
Merck KGaA
CDMOs
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »